Matt Whitmire
Vice President of FinanceMr. Matt Whitmire is Vice President of Finance of Janux Therapeutics, Inc. from August 2024. He oversees all aspects of the Financial Planning and Analysis (“FP&A”) function. Matt joined Janux in June 2021 and has finance and accounting experience, including the last six years at publicly held biopharmaceutical companies. Most recently, Matt served in both FP&A and clinical outsourcing capacities at Mirati Therapeutics. Prior to Mirati, Matt oversaw pricing and market analytics at Veyo Logistics, a medical transportation technology startup and was a Director at AArete, a global management consulting firm specializing in strategic profit improvement in the healthcare space. His career started with Ernst & Young LLP as a forensic accounting consultant. Matt holds a B.S. in Accounting (magna cum laude) from Santa Clara University and is a certified public accountant (inactive) in the State of California.
Positions
- Company NameJanux Therapeutics, Inc.Stock CodeJANXPositionVice President of FinanceColleagues
- DADavid Alan CampbellPresident, Co-Founder, CEO & Director
- RWRonald W. BarrettIndependent Chairperson
- TDThomas DiraimondoChief Scientific Officer
- JDJaneen DoyleChief Corporate & Business Development Officer
- MDMaria DobekVice President of Accounting
- JSJake SimsonIndependent Director
- VLVickie L. CappsIndependent Director
- WKWinston KungIndependent Director
